LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000314.8:c.763_773del
PTEN
· NP_000305.3:p.(Val255ProfsTer39)
· NM_000314.8
GRCh37: chr10:89717737 AGTAGAGTTCTT>A
·
GRCh38: chr10:87957980 AGTAGAGTTCTT>A
Gene:
PTEN
Transcript:
NM_000314.8
Final call
Likely Pathogenic
PVS1 very strong
PM2 supporting
Variant details
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Val255ProfsTer39)
gnomAD AF
ClinVar
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PVS1 (Very Strong): out-of-frame 11-nucleotide deletion p.(Val255ProfsTer39) places a premature stop at residue 293, 5' of the p.D375 threshold, predicted to trigger nonsense-mediated decay.
2
PM2 (Supporting): variant is absent (0 alleles) from gnomAD v2.1, gnomAD v4.1, and gnomAD-Canada v1.0.
3
PVS1 (Very Strong) plus PM2 (Supporting) satisfies the ClinGen PTEN VCEP Rule20 combination, yielding a final classification of Likely Pathogenic.
Final determination:
PTEN VCEP v3.2 Rule20: exactly 1 very strong pathogenic criterion (PVS1) plus exactly 1 supporting pathogenic criterion (PM2_Supporting) combines to Likely Pathogenic.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Met | Met (Very Strong): the 11-nucleotide out-of-frame deletion p.(Val255ProfsTer39) places a premature stop at residue 293, 5' of the p.D375 NMD threshold, predicting nonsense-mediated decay. |
cspec
vcep_pvs1_decisiontree_pten
|
| PS1 | N/A | Not applicable: this frameshift deletion is not a substitution, so no same-amino-acid comparison to a known pathogenic variant is possible. |
cspec
clinvar
|
| PS2 | Not assessed | Not assessed: no proband clinical data or parental testing were available to establish a proven de novo occurrence. |
cspec
clinvar
|
| PS3 | Not assessed | Not assessed: no variant-specific functional assay result was available; VCEP-calibrated PS3 thresholds cover only missense substitutions. |
cspec
vcep_mmc2
PMID:11237521
PMID:17218262
|
| PS4 | Not assessed | Not assessed: no proband phenotype data or case-control enrichment counts were available to score. |
cspec
clinvar
|
| PM1 | Not met | Not met: the deletion affects codon 255, outside the VCEP-defined catalytic motifs (residues 90-94, 123-130, 166-168), and no mutational hotspot was found. |
cspec
|
| PM2 | Met | Met (Supporting): 0 alleles in gnomAD v2.1, v4.1, and gnomAD-Canada v1.0, absent below the VCEP 0.001% population-frequency threshold. |
cspec
gnomad_v2
gnomad_v4
gnomad_canada
|
| PM3 | N/A | Not applicable: the PTEN VCEP v3.2 designates PM3 not applicable because PTEN-related disease is autosomal dominant. |
cspec
|
| PM4 | N/A | Not applicable: the deletion is out of frame (11 nucleotides), not an in-frame length change, so no protein-length alteration applies. |
cspec
|
| PM5 | N/A | Not applicable: this is a frameshift deletion rather than a missense change, so PM5's missense and BLOSUM62 comparisons cannot apply. |
cspec
clinvar
|
| PM6 | Not assessed | Not assessed: no proband or parental data were available to determine an assumed de novo occurrence. |
cspec
clinvar
|
| PP1 | Not assessed | Not assessed: no pedigree or segregation data were available for this variant. |
cspec
clinvar
|
| PP2 | N/A | Not applicable: PP2 addresses missense variants, and this variant is a frameshift deletion. |
cspec
|
| PP3 | N/A | Not applicable: PP3 is limited to missense variants (REVEL >0.7) and splice-relevant synonymous/intronic variants; this is a coding frameshift. |
cspec
spliceai
|
| PP4 | N/A | Not applicable: the PTEN VCEP captures phenotype specificity in PS4, and no proband phenotype data were available. |
cspec
|
| PP5 | N/A | Not applicable: the PTEN VCEP lists PP5 as not applicable, and no ClinVar expert-panel classification exists for this variant. |
cspec
clinvar
|
| BA1 | Not met | Not met: the variant is absent from gnomAD (0 alleles), far below BA1's required allele frequency above 0.056%. |
cspec
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS1 | Not met | Not met: absent from gnomAD (AF 0), below the BS1-supporting minimum allele frequency of 0.0000043. |
cspec
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS2 | Not met | Not met: zero alleles in population databases, so no homozygous observation in a healthy individual exists. |
cspec
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS3 | Not assessed | Not assessed: no functional assay evidence showing preserved function was available for this variant. |
cspec
vcep_mmc2
spliceai
PMID:11237521
PMID:17218262
|
| BS4 | Not assessed | Not assessed: no family-testing data exist; absent segregation information cannot be counted as documented lack of segregation. |
cspec
clinvar
|
| BP1 | N/A | Not applicable: the PTEN VCEP marks BP1 not applicable, and this truncating frameshift is the opposite of the missense BP1 targets. |
cspec
|
| BP2 | Not met | Not met: no observation of the variant in trans or in cis with a pathogenic PTEN variant exists (ClinVar has no entry). |
cspec
clinvar
|
| BP3 | N/A | Not applicable: PTEN VCEP v3.2 declares BP3 not applicable; the deletion is also out of frame, not an in-frame repeat indel. |
cspec
|
| BP4 | N/A | Not applicable: BP4 applies only to missense (REVEL <0.5) or synonymous/intronic variants; this frameshift is protein-truncating by mechanism. |
cspec
spliceai
|
| BP5 | Not assessed | Not assessed: no proband data on an alternate molecular diagnosis or non-overlapping family history were available. |
cspec
clinvar
|
| BP6 | N/A | Not applicable: the PTEN VCEP lists BP6 as not applicable, and no ClinVar expert-panel benign classification exists for this variant. |
cspec
clinvar
|
| BP7 | N/A | Not applicable: BP7 covers only synonymous or intronic variants; this variant is an exonic frameshift deletion. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.